Lanean...
Surrogate Endpoints in Pediatric Studies Submitted to the US FDA
The 21(st) Century Cures Act was passed in December, 2016, and included a number of provisions to facilitate drug approval. Considerable discussion was generated related to some aspects of the Act, especially to the use of surrogate endpoints (SEs) as a means to shorten the time required prior to re...
Gorde:
| Argitaratua izan da: | Clin Pharmacol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481930/ https://ncbi.nlm.nih.gov/pubmed/30094815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1117 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|